Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS MSCI Switzerland ETF CHF dis
CH0226274246 · CH0226274246 · CHF · domicile Switzerland
EquitySFDR art. 6
Index tracked: MSCI Switzerland Net Return CHF Index
- TER
- 0.20%+ trans. 0.01%
- Fund size
- —
- Tracking difference
- −0.13%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Physical
- Income
- Distributingmonthly
Launch 31 Oct 2013 · costs from the KID as of 26 Aug 2026 · 3 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
The investment objective of the subfund is to track the price and income performance before costs of the MSCI Switzerland Net Return CHF Index. This subfund invests in shares of companies that are included in the MSCI Switzerland Net Return CHF Index and in shares that are not represented in the MSCI Switzerland Net Return CHF Index but which have been announced to be included in the MSCI Switzerland Net Return CHF Index and other investments permitted under the fund contract. In principle, the performance of the MSCI Switzerland Net Return CHF Index is…
Performance since series start (in euro) — base 100
31 Oct 2013 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +14.2% |
| 3 years | +34.7% |
| 5 years | +36.3% |
| 10 years | +129.5% |
| Since series start | +186.3% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 11.71% | 12.62% | 13.46% |
| Max drawdown | −11.79% | −16.80% | −23.55% |
| Sharpe | 1.00 | 0.44 | 0.00 |
| Sortino | 1.44 | 0.59 | 0.00 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CH0226274246 · CH02262742461
RebalixCH0226274246 · CH0226274246 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +16.57% | +16.68% | −0.11% |
| 2024 | +5.40% | +5.52% | −0.12% |
| 2023 | +5.10% | +5.26% | −0.16% |
| 2022 | −17.21% | −17.06% | −0.15% |
| 2021 | +22.84% | +22.97% | −0.13% |
Distributions · per share, in CHF
Frequency: monthly · last 12 months: 0.2015 CHF (0.83% of NAV) · last ex-date 20 Apr 2026
| Year | Payments | Total (CHF) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.2015 | — |
| 2025 | 3 | 0.3945 | +1.97% |
| 2024 | 1 | 0.391 | +2.02% |
| 2023 | 1 | 0.368 | +1.96% |
| 2022 | 1 | 0.352 | +1.52% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
UFUJ · Börse Hamburg, Börse Hannover, Tradegate Exchange
+ 4 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/CH0226274246
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/CH0226274246
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · CH0226274246 · CH02262742462